Cat.#: ACPP-1844
| Despition | GCLM Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1286 | Bestrophin 2 Blocking Peptide (AC1286) | 250 µg | inquiry |
| ACPP-1132 | Recombinant Human Calbindin Protein (AC1132) | 25 µl | inquiry |
| ACPP-1661 | Human HEXA Protein, Sf9 (AC1661) | 2 µg | inquiry |
| ACPP-1755 | Human PDGFD Protein (AC1755) | 5 µg | inquiry |
| ACPP-1383 | Human KLF7 Protein (AC1383) | 5 µg | inquiry |
| ACPP-1201 | HAND2 Blocking Peptide (AC1201) | 250 µg | inquiry |
| ACPP-1669 | Human NRGN Protein (AC1669) | 2 µg | inquiry |
| ACPP-1099 | Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) | 10 µg | inquiry |
| ACPP-1457 | Rat NME2 Protein (AC1457) | 5 µg | inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.